Peginesatide: A Potential Erythropoiesis Stimulating Agent for the Treatment of Anemia Of Chronic Renal Failure

Peginesatide: A Potential Erythropoiesis Stimulating Agent for the Treatment of Anemia Of Chronic Renal Failure


Identification: nnj_nd10A2
Issue: November-December 2010
Volume: Vol. 37, No. 6

Standard: $30.00

Description

This article is available to members for free.

Acknowledgments, Sources of Support, and Disclaimers: Medical writing and editorial assistance provided by Norma Padilla, PhD, and Sophia Shumyatsky, PharmD, of ApotheCom Associates, and supported by Affymax and Takeda Pharmaceuticals North America, Inc.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content